JAK inhibitor works well with topical corticosteroids in atopic dermatitis

Baricitinib, an oral JAK inhibitor, is effective as treatment for moderate to severe atopic dermatitis when used in combination with topical steroids, a phase 3 randomised controlled trial has shown. Published in JAMA Dermatology, the international multicentre trial involved 329 adults with moderate to severe AD, treated at 68 centres including five clinics in Australia. ...

Already a member?

Login to keep reading.

© 2021 the limbic